INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 169 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $22,000 | +266.7% | 200 | +100.0% | 0.00% | +300.0% |
| Q1 2018 | $6,000 | -66.7% | 100 | -66.7% | 0.00% | -66.7% |
| Q4 2017 | $18,000 | +5.9% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $17,000 | -52.8% | 300 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $36,000 | +5.9% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $34,000 | +3.0% | 300 | 0.0% | 0.01% | -25.0% |
| Q4 2016 | $33,000 | -32.7% | 300 | 0.0% | 0.01% | -38.5% |
| Q3 2016 | $49,000 | +14.0% | 300 | 0.0% | 0.01% | +8.3% |
| Q2 2016 | $43,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |